Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series.

Kanda, Yoshinobu; Mori, Takehiko; Narita, Atsushi; Wolter, Kevin D; Yoshimatsu, Hiroki; Nishimura, Kazuma

Kanda, Yoshinobu; Mori, Takehiko; Narita, Atsushi; Wolter, Kevin D; Yoshimatsu, Hiroki; Nishimura, Kazuma.

Afiliación

Kanda Y; Division of Hematology, Department of Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke-Shi, Tochigi-Ken, 329-0498, Japan. ycanda-tky@umin.ac.jp.
Mori T; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Narita A; Department of Hematology, Tokyo Medical and Dental University, Tokyo, Japan.
Wolter KD; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yoshimatsu H; Pfizer Inc, New York, NY, USA.
Nishimura K; Pfizer R&D Japan, Tokyo, Japan.

Int J Hematol ; 117(1): 37-43, 2023 Jan.

Article en En | MEDLINE | ID: mdl-36441357

Asunto(s)

Anemia Aplásica; Suero Antilinfocítico; Humanos; Animales; Caballos; Suero Antilinfocítico/efectos adversos; Anemia Aplásica/tratamiento farmacológico; Pueblos del Este de Asia; Ciclosporina; Linfocitos T; Inmunosupresores/efectos adversos; Resultado del Tratamiento

Palabras clave

Aplastic anemia; Equine anti-thymocyte immunoglobulin; Hematologic response; Safety; eATG

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Anemia Aplásica / Suero Antilinfocítico Tipo de estudio: Clinical_trials Límite: Animals / Humans Idioma: En Revista: Int J Hematol Asunto de la revista: HEMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google